Retatrutide represents a unique molecule exhibiting significant promise in physique regulation. This treatment acts as a dual agonist for both GLP-1 and GIP pathways , leading better glycemic control and lower abdominal adipose tissue . Initial patient findings indicate impressive weight decrease and positive health outcomes in subjects with obesit